Na dis kin mek yu bɔdi de at ɛn yu skin kin chenj? Lɛ wi tɔk bɔt Eosinophilia-Myalgia Syndrome (EMS)!

Sɔntɛnde, i nɔ kin izi fɔ ɔndastand di sik dɛn we wi kin gɛt, nɔto so? Wantɛm wantɛm, wi kin fil pen na wi bɔdi, smɔl smɔl tin dɛn kin apia na wi skin, ɛn i kin at fɔ blo smɔl. Tide wi go tɔk bɔt wan sik wae nɔr kin bɔrku bɔt wae de mɔna pipul dɛm wae kin kam wit dɛn kayn sik ya wae kin tan lɛk se nɔr gɛt natin fɔ du wit dɛnsɛf. Dɛn kɔl dis `Eosinophilia-Myalgia Syndrome` (EMS). Pan ɔl we i go tan lɛk se di nem lɔng smɔl, lɛ wi ɔndastand am simpul wan.

Wetin na di sik we dɛn kɔl Eosinophilia-Myalgia Syndrome (EMS)?

Fɔ tɔk am simpul wan, `Eosinophilia-Myalgia Syndrome` (EMS) na wan sik we nɔ kin apin so ɔltɛm we kin afɛkt yu mɔsul dɛm, yu skin, ɛn yu lɔng dɛm . wetin de apin insay dis na dat wan kayn wayt bכdi sεl we dεn kכl `eosinophils` , we de insay wi bכdi, de kכmכt pasmak εn de put insεf insay wi tisu dεm. Tink bɔt am dis we, dɛn `eosinophils` ya tan lɛk wi bɔdi in sikyɔriti gad dɛm. Bɔt we dɛn sojaman dɛn ya bɔku pasmak, dɛn kin bigin fɔ kɔz prɔblɛm to wi yon bɔdi.

Dis sik kin mek yu mɔsul dɛn gɛt siriɔs pen (myalgia) , yu skin kin rɔsh ɔ ɔda chenj dɛn, ɛn i kin at fɔ blo . Sɔmtɛm dɛn sik ya kin mek pɔsin in layf de pan denja ɔ kin mek i fil bad bad wan we kin mek i nɔ izi fɔ du tin dɛn we pɔsin kin du ɛvride.

dis kכndyushכn we dεn kכl `EMS` na sכbtayp fכ כda kכndyushכn we dεn kכl `eosinophilia`. `Eosinophilia` na jכs inkrεs pan di nכmba fכ `eosinophils` na di bכdi כ di tisu dεm.

Di tin we kin mek pɔsin gɛt EMS pas ɔl na we dɛn de yuz sɔpɔtmɛnt dɛn we gɛt kemikal dɛn we dɛn kɔl L-tryptophan ɔ 5-hydroxytryptophan (5-HTP), lɛk aw yu dɔn yɛri. Bɔt dɛn dɔn si bak se sɔm pipul dɛn kin gɛt dis sik we dɛn nɔ yuz dɛn tin ya.

Aw Eosinophilia-Myalgia Syndrome bin bi wan sik we de prɛd?

Dis stori ol smɔl. Insay 1989, wan nyu sik bin kam na Amɛrika wantɛm wantɛm. Risach pipul dεm gi am di nem `Eosinophilia-Myalgia Syndrome`. Da tɛm de, i bin de skata lɛk wan sik we de prɛd. כl di pipul dεm we bin sik dis we na dεn wan dεm we bin de yuz supliment we gεt atifishal `L-tryptophan` . dis bin mek di `eosinophils` dεm de kכlכp na dεn bכdi, we de mek di mכsul dεm de pen. Dɛn se na lɛk 37 pipul dɛn bin day da tɛm de.

Fɔ fala dis tin we apin, di US Food and Drug Administration (FDA) bin pul bɔku prɔdak dɛn we gɛt L-tryptophan na di makit. Afta dat, di nɔmba fɔ di EMS kes dɛm we dɛn ripɔt bin go dɔŋ bad bad wan.

כltu, leta dεn supliment kכmpani dεm de riples `L-tryptophan` wit in vεri sεm kayn `5-hydroxytryptophan (5-HTP)`.A bigin fɔ yuz wetin dɛn de tɔk. Dɛn `supliment` ya min tin dɛm lɛk fɔ mek yu slip fayn, fɔ mek yu fil fayn, ɛn ɔda tin dɛm Yu kin dɔn si dɛn tin ya as prɔdak dɛm we de mek yu bɔdi fit, ridyus yu wet, ɔ ɛp yu fɔ slip. So, possibiliti de se `EMS` kin apin as sayd ifekt fכ dεn tin ya.

I sɔri fɔ no se, wit di chenj we dɛn chenj di rigyuleshɔn dɛn we gɛt fɔ du wit it sɔpɔtmɛnt dɛn na Amɛrika insay 1994, sɔpɔtmɛnt dɛn we gɛt sɛntetik L-tryptophan ɛn 5-HTP dɔn apia bak na di makit.

Udat dis tin kin afɛkt mɔ?

Insay di 1989 pandemik, di mɔtalman we bin sɔfa wit dis `EMS` kɔndishɔn na di wan dɛn we tek `supliment` we gɛt `L-tryptophan` ɔ `5-HTP`. Pan dɛn pipul ya, dɛn bin se bɔku pan dɛn na uman dɛn .

Naw, dis sik nɔ kin apin so ɔltɛm. Bɔt as wi bin dɔn tɔk, pipul dɛn we nɔ yuz prɔdak we gɛt `L-tryptophan` ɔ `5-HTP` kin gɛt dis `EMS` sik bak.

Aw kɔmɔn tin dis?

Nɔr ɛksaktɔl statystik nɔr de fɔ aw dis kin kɔmɔn. Dɛn se insay 1989 we di sik bin de, na Amɛrika nɔmɔ dɛn bin gɛt bitwin 5,000 to 10,000 pipul dɛn we gɛt di sik. Insay da sem tɛm de, dɛn bin ripɔt di kes dɛn bak frɔm kɔntri dɛn lɛk Jamani, Kanada, ɛn Yunaytɛd Kiŋdɔm.

Wetin na di sayn dɛm fɔ Eosinophilia-Myalgia Syndrome (EMS)?

Di sayn dɛm fɔ EMS kin difrɛn frɔm wan pɔrsin to ɔda pɔrsin, ɛn dɛn kin difrɛn pan aw dɛn kin tranga. Dɛn sayn ya kin bigin wantɛm wantɛm. Dɛn simptom ya kin kam bikɔs di eosinofil dɛn kin gɛda na di blɔd ɛn di tisu dɛn, we kin mek di bɔdi inflamɛns. Dɛn kin afɛkt bɔku difrɛn pat dɛn na di bɔdi.

Di sayn dɛm we dɛn kin si bɔku tɛm na:

• Taya .
• Fiva .
• Di an ɛn fut dɛn kin swel (ɛdima) .
• Di an ɛn fut dɛn we nɔ gɛt bɛtɛ trɛnk .
• I nɔ kin izi fɔ mɛmba ɔ fɔ pe atɛnshɔn .
• Di chenj dɛn we pɔsin kin chenj pan di we aw pɔsin de fil ɔ di we aw i de biev .
• Nɔs ɔ vɔmit .
• Rɔnbɛlɛ .

Apat frɔm dat, sɔm patikyula sayn dɛn kin apin bak na di mɔsul dɛn, di skin, di at, ɛn di lɔng dɛn.

Di sayn dɛm we gɛt fɔ du wit di mɔsul ɛn jɔyn

wan pan di men tin dεm we `EMS` de du na dεn ifekt dεm ya pan di mכsul dεm εn di jכint dεm:

• Pen (`myalgia` ɔ `arthralgia`) : Dis na di men tin. Di bɔdi de at, di jɔyn dɛn de at.
• Di bɔdi de pen .
• Di mɔsul dɛn we kin tayt wantɛm wantɛm ɛn we kin spam .
• Wik .
• Di mɔsul ɔ jɔyn dɛn we nɔ de wok fayn .

De pen wae yu kin fil kin de frɔm wae yu nɔr de fil to wae yu de fil bad. I kin ivin wɔs fɔ sɔm wiks.

Di sayn dɛn we pɔsin kin si na di skin

Di sayn dɛm na di skin kin te fɔ lɛk tri to siks mɔnt. Dɛn tin ya na:

• Wan skin we de rɔsh: Sɔntɛm i gɛt rɛd ɛn blista.
• Skin we de it .
• Pat dɛn na di skin we gɛt ia we de lɔs .
• Tik pat dεm na di skin : dεn kכl dis fכ mεdikal `eosinophilic fasciitis`.

Di simptom dɛm na di at ɛn lɔng

Di sayn dɛm wae kin afɛkt di lɔng kin smɔl lɛk kɔf, ɔr kin tranga pasmak. If yu gɛt ɛni wan pan dɛn sayn ya, yu fɔ go na imejensi rum wantɛm wantɛm :

• I nɔ kin izi fɔ yu fɔ blo .
• Di shɔt we aw yu de blo .
• Chɛst pen .
• Wan at we nɔ de bit ɔltɛm (ari at) .
• Inflameshɔn na di at mɔsul (`myocarditis`) .

Impɔtant: If yu gɛt prɔblɛm fɔ blo, yu chɛst de pen, ɔ yu at de bit we nɔ fayn, nɔ ple. Go to dɔktɔ wantɛm wantɛm.

Wetin kin mek pɔsin gɛt Eosinophilia-Myalgia Syndrome (EMS)?

We dɛn bin fɔs fɛn EMS insay 1989, dɛn bin tink se na wan wɛlbɔdi sɔpɔt we gɛt sɛntetik L-triptophan . L-tryptophan na wan amino asid we de na di nכmal tin we de insay sכm it dεm lεk tכki. כltu, we dεn mek am sεntetik wan, dεn sho se i de mek di mכsul dεm pen εn di εosinophil lεvεl dεm go εlevεt.

Pan ɔl we prɔdak dɛn we gɛt sɛntetik L-triptofan stil de na di makit tide, EMS kin kɔmɔt bak frɔm ɔda sintetik tin we fiba L-triptofan, we dɛn kɔl 5-HTP .

Bɔt sɔm EMS pasɛnt dɛn de we nɔ yuz ɛnitin we gɛt L-tryptophan ɔ 5-HTP. Dis min se ɔda tin kin de fɔ dis sik. Risach stil de go bifo.

Aw dɛn kin no se pɔsin gɛt Eosinophilia-Myalgia Syndrome (EMS)?

Dɔktɔ go no if yu gɛt EMS bay we i go chɛk yu ɛn du di tɛst dɛn we yu nid. Di men tin dɛm we di dɔktɔ go luk fɔ we dɛn de du dis ɛgzam na:

• Dɛn go chɛk wan blɔd sɛmpul frɔm yu fɔ si if di eosinophils dɔn bɔku.
• A de chɛk fɔ si if yu gɛt mɔsul pen.

Dɛn kin du bɔku ɔda blɔd tɛst fɔ no if pɔsin gɛt dis sik. Dɛn tin ya na fɔ pul ɔda tin dɛn we gɛt di sem kayn sik. Di dɔktɔ go aks yu bak bɔt yu mɛdikal istri ɛn ɛni sɔpɔtmɛnt we yu de tek . in patikyula, mek sכh se dεn gεt `L-tryptophan` כ `5-HTP`.

Aw dɛn kin trit di sik we dɛn kɔl Eosinophilia-Myalgia Syndrome (EMS)?

No patikyula, wan tritmɛnt nɔ de fɔ EMS. Yu dɔktɔ go mek wan tritmɛnt plan we dɛn mek fɔ yu fɔ ɛp yu fɔ kɔntrol yu sik dɛn. Dis kin inklud dɛn mɛrɛsin ya:

• Di tin dɛn we de mek di mɔsul dɛn rilaks .
• Di mɛrɛsin dɛn we de mek pɔsin fil pen (`analjɛsik`) .
• Mεdisin dεm we de pul εkstra wata na di bכdi (diuretics) - if swεla de.
• Kɔtikosterɔyd - Dis na wan kayn mɛrɛsin we dɛn kin gi fɔ ridyus inflamɛns.

Di tin we impɔtant pas ɔl na fɔ tek tɛm rid di lɛbl fɔ ɛni sɔpɔt we yu tek. Ɛn tɔk to yu dɔktɔ bɔt di tin dɛn we yu go yuz fɔ mek di it. If dɛn gɛt `L-tryptophan` ɔ `5-HTP`, yu fɔ stɔp fɔ tek dɛn wantɛm wantɛm.

Dipen pan aw yu mɔsul dɛn de fil bad, yu dɔktɔ kin tɛl yu fɔ stɔp fɔ du bɔku tin fɔ mek di pen nɔ wɔs. Bɔt sɔm pipul dɛn dɔn si se fɔ ɛksesaiz wit layt ɔltɛm we dɛn de du tritmɛnt kin ɛp fɔ mek dɛn nɔ fil pen.

Yu tink se dɛn kin ebul fɔ protɛkt di sik we dɛn kɔl Eosinophilia-Myalgia Syndrome (EMS)?

Bikɔs nɔto ɔl di tin dɛn we kin mek pɔsin gɛt EMS, dɛn nɔ ɔndastand am gud gud wan, no wan we nɔ de fɔ mek i nɔ apin. Bɔt yu kin ridyus yu risk bay we yu avɔyd sɔpɔtmɛnt dɛn we gɛt L-tryptophan ɔ 5-HTP.

If a gɛt Eosinophilia-Myalgia Syndrome (EMS), wetin a fɔ ɛkspɛkt?

Eosinophilia-Myalgia Syndrome (EMS) na wan sik wae nɔr de mɛn , dat min se dɛn nɔr kin ebul fɔ mɛn am ɛn i kin te fɔ lɔng tɛm. Yu sik kin kam ɛn go ɔlsay na yu layf. Pan ɔl we di sik dɛn bin de mek pɔsin in layf de pan denja insay di 1989 pandemik, wit tritmɛnt dɛn we de tide, yu kin ebul fɔ kɔntrol yu sik dɛn ɛn mek yu nɔ gɛt siriɔs prɔblɛm dɛn. Risach pipul dɛm stil de stɔdi if dis sik go afɛkt yu layf.

Fɔ sɔm pipul dɛn, apat frɔm we dɛn de tek mɛrɛsin, we dɛn de du layt bɔdi ɛvride, dat kin ɛp fɔ mek dɛn nɔ fil pen ɛn nɔ fil fayn. Yu dɔktɔ go tɔk to yu bɔt aw yu fɔ chenj yu layf we yu de trit yu.

Ustɛm a fɔ go to dɔktɔ?

If yu gɛt siriɔs mɔsul pen we so bad dat yu nɔ ebul fɔ du yu ɛvride wok, ɔ ivin du ɔdinari wok dɛn, yu fɔ rili go to dɔktɔ.

Dɔn bak, if yu gɛt ɛni wan pan dɛn bad bad sayn ya we de afɛkt yu at ɔ yu lɔng, go na imejensi rum wantɛm wantɛm:

• I nɔ kin izi fɔ yu fɔ blo .
• Chɛst pen .
• Wan prɔblɛm we de mek pɔsin in at ritm .

Us kwɛstyɔn dɛn a fɔ aks mi dɔktɔ?

We yu go si dɔktɔ, yu kin aks kwɛstyɔn dɛn lɛk dɛn wan ya:

• A gɛt Eosinophilia-Myalgia Syndrome (EMS) ɔ ɔda kayn sik we tan lɛk dis?
• Dis `EMS` kondishon na di supliment dem we a tek?
• Wetin na di bad tin dɛn we dɛn tritmɛnt ya kin du?
• Aw a fɔ de du tin wit mi bɔdi?
• A nid fɔ mek ɛni chenj na mi layf?

Fɔ dɔn, mɛmba dis (Take-Home Message) .

Eosinophilia-Myalgia Syndrome (EMS) na wan sik wae nɔr de dɔn ɛn wae kin afɛkt sɔm pat dɛm na yu bɔdi. Di bɛst we fɔ ridyus yu risk na fɔ avɔyd fɔ tek sɔpɔtmɛnt dɛn we gɛt sɛntetik L-tryptophan ɔ 5-HTP. I sef fɔ it L-tryptophan, we natin nɔ de fɔ it lɛk tik ɛn tin fish, bɔt tin dɛn we dɛn mek wit tin dɛn kin ambɔg yu bɔdi.

Pan ɔl we di tritmɛnt na fɔ kɔntrol yu sayn dɛm, yu kin nid fɔ ad tin dɛm bak to yu layf, lɛk fɔ ɛksesaiz layt ɛvride, fɔ ɛp yu fɔ fil fayn. Mɛmba ɔltɛm se if yu gɛt ɛnitin we nɔ kɔmɔn, mɔ afta yu dɔn bigin fɔ tek nyu supamakit, go to dɔktɔ wantɛm wantɛm.

` eosinophilia-myalgia syndrome, EMS, mכsul pen, skin sik, L-tryptophan, 5-HTP, it supliment, supliment, eosinophils, eosinophils, Sri Lanka Wεlth